Abstract:p16 INK4a and p21 WAF1/Cip1 are cyclin‐dependent kinase inhibitors involved in cell cycle control, which can function as oncogenes or tumor suppressors, depending on the context of various extracellular and intracellular signals, and cell type. In human papillomavirus‐induced cervical cancer, p16 INK4a shows oncogenic activity and functions as a diagnostic marker of cervical neoplasia, whereas p21 WAF1/Cip1 acts as a tumor suppressor and its downregulation is associated with the progression of malignant transformation. Several histone deacetylase (HDAC) inhibitors promote the positive and negative regulation of a number of genes, including p16 INK4a and p21 WAF1/Cip1 ; however, the effects of sodium valproate (VPA) on these genes and on the proteins they encode remain uncertain in HeLa cervical cancer cells. In the present study, these effects were investigated in HeLa cells treated with 0.5 or 2 mM VPA for 24 h, using reverse transcription‐quantitative PCR, confocal microscopy and western blotting. The results revealed a decrease in the mRNA expression levels of p16 INK4a and a tendency for p16 INK4a protein abundance to decrease in the presence of 2 mM VPA. By contrast, an increase in the protein expression levels of p21 WAF1/Cip1 was detected in the presence of 0.5 and 2 mM VPA. Furthermore, VPA was confirmed to inhibit HDAC activity and induce global hyperacetylation of histone H3. Notably, VPA was shown to suppress p16 INK4a , a biomarker gene of cervical carcinoma, and to increase the abundance of the tumor suppressor protein p21 WAF1/Cip1 , thus contributing to the basic knowledge regarding the antitumorigenic potential of VPA. Exploration of epigenetic changes associated with the promoters of p16 INK4a and p21 WAF1/Cip1 , such as histone H3 methylation, may provide further information and improve the understanding of these findings.

Sodium valproate induces cycle arrest, apoptosis and elevates P21WAF1 mRNA expression in chronic myeloid leukemia cell line K562

Effects of Sodium Valproate on Proliferation and Apoptosis of Chronic Myeloid Leukemia Cell Line K562

Analyzing gene expression profile in K562 cells exposed to sodium valproate using microarray combined with the connectivity map database.

Using an Exon Microarray to Identify a Global Profile of Gene Expression and Alternative Splicing in K562 Cells Exposed to Sodium Valproate

Vaproate Induces Differentiation and Apoptosis of Myeloid Leukemia Cells and the Related Mechanisms

Sodium valproate affects the expression of p16 INK4a and p21 WAFI/Cip1 cyclin‐dependent kinase inhibitors in HeLa cells

Inhibitory Effect of Valproate on Proliferation of Human Kidney Carcinoma ACHN Cells and Its Mechanism

Quantitative Analysis of Global Proteome and Lysine Acetylome Reveal the Differential Impacts of VPA and SAHA on HL60 Cells

Induction of Differentiation and Apoptosis of Sodium Valproate on Kasumi-1 Cells

The Impact of Chlorambucil and Valproic Acid on Cell Viability, Apoptosis and Expression of p21, HDM2, BCL2 and MCL1 Genes in Chronic Lymphocytic Leukemia

Synergistic Effect of Bortezomib and Valproic Acid Treatment on the Proliferation and Apoptosis of Acute Myeloid Leukemia and Myelodysplastic Syndrome Cells

Analyzing the Molecular Mechanisms in Sodium Valproate-Induced Differentiation of NB4 Cells Using Microarray Combined with the MAS Tool

Valproic Acid Influences MTNR1A Intracellular Trafficking and Signaling in a β-Arrestin 2-Dependent Manner

Anticancer Effects of Valproic Acid on Oral Squamous Cell Carcinoma Via Sumoylation in Vivo and in Vitro

Valproic Acid Combined with Zoledronate Enhance Γδ T Cell-Mediated Cytotoxicity Against Osteosarcoma Cells Via the Accumulation of Mevalonate Pathway Intermediates.

Molecular marker associated with valproate induced differentiation in myeloid leukemia cells

[Apoptosis-Inducing Effect of Valproic Acid Combined with Arsenic Trioxide on RPMI 8226 Cells and Its Mechanism].

Study on the mechanism of sodium valproate combined with G-CSF induced myeloid leukemia cell differen-tiation

An integrated RNA-Seq and network study reveals that valproate inhibited progesterone production in human granulosa cells

Valproic acid suppresses cervical cancer tumor progression possibly via activating Notch1 signaling and enhances receptor-targeted cancer chemotherapeutic via activating somatostatin receptor type II

Antitumor activity of sodium valproate in cultures of human neuroblastoma cells